文献速递乳腺技术与安全CTMR

同步光谱CT图与乳腺MRI衍生的定量CT数据及MRI生物标志物与浸润性导管乳腺癌分子标志物的跨模态相关性研究

Intermodal correlation of quantitative CT-data and MRI-biomarkers derived from synchronous spectral CT-maps and breast MRI-examinations with molecular biomarkers in invasive ductal breast carcinomas.
PubMed 文献 · Eur J Radiol · 2023-06-05

研究前瞻性纳入2016至2020年接受双层CT和乳腺MRI分期的浸润性导管乳腺癌患者,分析碘浓度图、有效原子序数图与MRI信号强度、ADC及动态曲线类型和分子标志物的相关性。结果显示碘含量与Zeff值同免疫组化亚型呈中等强度相关,T2w信号比值和动态曲线趋势与亚型、分级及Ki-67相关,ADC与HER2仅弱相关。作者认为双层CT灌注数据和MRI生物标志物与免疫组化亚型相关,但需进一步临床研究验证。

要点

  • 乳腺病灶碘含量和Zeff值与免疫组化亚型呈中等强度相关(r=0.211-0.243)。
  • Zeff值经肌肉和主动脉归一化后与亚型相关性最强(r=-0.237至-0.305)。
  • 动态曲线趋势比值与肿瘤分级中等相关(r=-0.213和-0.194),与Ki-67低度相关(r=-0.160)。

核心结论

  • 初步结果表明,基于双层CT的灌注数据和MRI生物标志物与浸润性导管乳腺癌的免疫组化亚型存在相关性,需进一步临床研究验证其价值并明确适用临床场景。

研究设计与样本

  • 前瞻性纳入2016至2020年大学乳腺癌症中心因浸润性导管乳腺癌分期而行临床指征双层CT扫描和乳腺MRI的患者;从CT数据集重建碘浓度图和Zeffective图,从MRI数据集获取T1w和T2w信号强度、ADC及动态曲线聚类形状(廓清、平台、持续);采用专用软件在相同解剖位置对肿瘤和参考肌肉进行半自动ROI评估;统计分析主要为描述性,使用Spearman秩相关和(多变量)偏相关。

关键影像表现/征象

  • 乳腺目标病灶增强动力学第3期信号强度与碘含量和Zeffective值呈中等强度相关(Spearman r=0.237/0.236,p=0.002/0.003)。
  • 乳腺目标病灶T2w信号强度与肌肉比值同免疫组化亚型呈中等至高度相关(r=0.232-0.249,p=0.003/0.002)。
  • 乳腺目标病灶与肌肉动态曲线趋势比值同免疫组化亚型呈低至中等强度相关(r=-0.322/-0.245,p<0.001/0.002)。

诊断标准与关键数值

  • 乳腺目标病灶碘含量和Zeff值与免疫组化亚型相关(双变量和多变量分析r=0.211-0.243,p=0.002-0.009)。
  • Zeff值经肌肉和主动脉归一化后与亚型相关性最强(r=-0.237至-0.305,p<0.001-0.003)。
  • 动态曲线趋势比值与肿瘤分级中等相关(r=-0.213和-0.194,p=0.007/0.016),与Ki-67低度相关(双变量分析r=-0.160,p=0.040)。
  • 乳腺目标病灶ADC值与HER2表达仅弱相关(双变量分析r=0.191,p=0.030)。

局限性

  • 原文结论指出需进一步临床研究以验证结果价值并明确所述双层CT生物标志物和MRI生物标志物可能有助于临床患者管理的临床情境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To asses the correlation of data derived from dual-layer (DL)-CT material-maps and breast MRI data with molecular biomarkers in invasive breast carcinomas.

METHODS: All patients at the University Breast Cancer Center who underwent a clinically indicated DLCT-scan and a breast MRI for staging of invasive ductal breast cancer from 2016 to 2020 were prospectively included. Iodine concentration-maps, and Zeffective-maps were reconstructed from the CT-datasets. T1w- and T2w-signal intensities, ADC and the clustered shapes of the dynamic-curves (washout, plateau, persistent) were derived from the MRI-datasets. ROI-based evaluations of the cancers and the reference "musculature" were performed semi-automatically in identical anatomical positions using dedicated evaluation software. Statistical analysis was essentially descriptive using Spearmańs rank correlation and (multivariable) partial correlation.

RESULTS: The signal intensities measured in the 3rd phase of the contrast dynamics correlated at an intermediate level of significance with the iodine content and the Zeffective-values derived from the breast target lesions (Spearmańs rank correlation-coefficient r = 0.237/0.236, p = 0.002/0.003). The bivariate and the multivariate analyses displayed correlations of an intermediate significance level of the iodine content and the Zeff-values measured in the breast target lesions with immunhistochemical subtyping (r = 0.211-0.243, p = 0.002-0.009, respectively). The Zeff-values showed the strongest correlations when normalized to the values measured in the musculature and in the aorta (r = -0.237 to -0.305, r=<0.001-0.003). The MRI-assessments showed correlations of intermediate to high significance and low to intermediate significance between the ratios of the T2w-signal intensities and the trends of the dynamic curves measured in the breast target lesions and in musculature and immunohistochemical cancer subtyping, respectively (T2w: r = 0.232-0.249, p = 0.003/0.002; dynamics: r = -0.322/-0.245, p=<0.001/0.002). The ratios of the clustered trends of the dynamic curves measured in the breast target lesions and in musculature correlated with tumor grading on intermediate significance level (r = -0.213 and -0.194, p = 0.007/0.016) and with Ki-67 on a low significance level (bivariate analysis: r = -0.160, p = 0.040). There was only a weak correlation between the ADC-values measured in the breast target lesions and HER2-expression (bivariate ansalysis: r = 0.191, p = 0.030).

CONCLUSIONS: Our preliminary results indicate that evaluation of perfusion based DLCT-data and MRI-biomarkers show correlations with the immunhistochemical subtyping of invasive ductal breast carcinomas. Further clinical research is warranted in order to validate the value of the results and define clinical situations in which the use of the described DLCT-biomaker and MRI biomarkers may be helpful in clinical patient care.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Klein, Gabriel Schafigh, Schömig-Markiefka, et al. Intermodal correlation of quantitative CT-data and MRI-biomarkers derived from synchronous spectral CT-maps and breast MRI-examinations with molecular biomarkers in invasive ductal breast carcinomas. Eur J Radiol. 2023. PMID: 37302338. doi:10.1016/j.ejrad.2023.110919

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。